Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation

Genes and Nutrition

Volumn 9, Issue 5, 2014, Pages

  Giacconi, Robertina ^a   Simm, Andreas ^b   Santos, Alexander Navarrete ^b   Costarelli, Laura ^a   Malavolta, Marco ^a   Mecocci, Patrizia ^c   Piacenza, Francesco ^a   Basso, Andrea ^a   Fulop, Tamas ^d   Rink, Lothar ^e   Dedoussis, George ^f   Kanoni, Stavroula ^g   Herbein, Georges ^h   Jajte, Jolanta ⁱ   Mocchegiani, Eugenio ^a  

^a INRCA   (Italy)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

^e RWTH AACHEN UNIVERSITY   (Germany)

^f HAROKOPIO UNIVERSITY   (Greece)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^h Hôpital Saint Jacques   (France)

ⁱ MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Advanced glycation end products (AGEs); Aging; Intracellular free zinc; MT1A polymorphism; Zinc supplementation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE; CATALASE; GLUTATHIONE PEROXIDASE; LIPID; LYSINE; METALLOTHIONEIN 1A; METALLOTHIONEIN I; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ZINC ASPARTATE; ZINC ION;

AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CELL LEVEL; DIET SUPPLEMENTATION; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL;

EID: 84943015114     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-014-0426-2     Document Type: Article

References (51)

1. Ando R, Ueda S, Yamagishi S, Miyazaki H, Kaida Y, Kaifu K, Yokoro M, Nakayama Y, Obara N, Fukami K, Takeuchi M, Okuda S (2013) Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction. Diab Vasc Dis Res 10:436–441. doi:10.1177/1479164113486662
2. Andriollo-Sanchez M, Hininger-Favier I, Meunier N, Venneria E, O’Connor JM, Maiani G, Polito A, Bord S, Ferry M, Coudray C, Roussel AM (2008) No antioxidant beneficial effect of zinc supplementation on oxidative stress markers and antioxidant defenses in middle-aged and elderly subjects: the Zenith study. J Am Coll Nutr 27:463–469
3. Bao B, Prasad AS, Beck FW, Snell D, Suneja A, Sarkar FH, Doshi N, Fitzgerald JT, Swerdlow P (2008) Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Transl Res 152:67–80. doi:10.1016/j.trsl.2008.06.001
4. Bao B, Prasad AS, Beck FW, Fitzgerald JT, Snell D, Bao GW, Singh T, Cardozo LJ (2010) Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 91:1634–1641. doi:10.3945/ajcn.2009.28836
5. Barbato JC, Catanescu O, Murray K, DiBello PM, Jacobsen DW (2007) Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis. Arterioscler Thromb Vasc Biol 27:49–54
6. Basta G, Schmidt AM, De Caterina R (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582–592
7. Beattie JH, Gordon MJ, Duthie SJ, McNeil CJ, Horgan GW, Nixon GF, Feldmann J, Kwun IS (2012) Suboptimal dietary zinc intake promotes vascular inflammation and atherogenesis in a mouse model of atherosclerosis. Mol Nutr Food Res 56:1097–1105. doi:10.1002/mnfr.201100776
8. Colvin RA, Holmes WR, Fontaine CP, Maret W (2010) Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics 2:306–317. doi:10.1039/b926662c
9. Cortese-Krott MM, Suschek CV, Wetzel W, Kroncke KD, Kolb-Bachofen V (2009) Nitric oxide-mediated protection of endothelial cells from hydrogen peroxide is mediated by intracellular zinc and glutathione. Am J Physiol Cell Physiol 296:C811–C820. doi:10.1152/ajpcell.00643.2008
10. Costarelli L, Muti E, Malavolta M, Cipriano C, Giacconi R, Tesei S, Piacenza F, Pierpaoli S, Gasparini N, Faloia E, Tirabassi G, Boscaro M, Polito A, Mauro B, Maiani F, Raguzzini A, Marcellini F, Giuli C, Papa R, Emanuelli M, Lattanzio F, Mocchegiani E (2010) Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects. J Nutr Biochem 21:432–437. doi:10.1016/j.jnutbio.2009.02.001
11. Daroux M, Prevost G, Maillard-Lefebvre H, Gaxatte C, D’Agati VD, Schmidt AM, Boulanger E (2010) Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes Metab 36:1–10. doi:10.1016/j.diabet.2009.06.005
12. de Vos LC, Mulder DJ, Smit AJ, Dullaart RP, Kleefstra N, Lijfering WM, Kamphuisen PW, Zeebregts CJ, Lefrandt JD (2014) Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol 34:933–938. doi:10.1161/ATVBAHA.113.302731
13. Giacconi R, Muti E, Malavolta M, Cipriano C, Costarelli L, Bernardini G, Gasparini N, Mariani E, Saba V, Boccoli G, Mocchegiani E (2007) The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol Med 13:388–395
14. Giacconi R, Bonfigli AR, Testa R, Sirolla C, Cipriano C, Marra M, Muti E, Malavolta M, Costarelli L, Piacenza F, Tesei S, Mocchegiani E (2008) +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metab 94:98–104. doi:10.1016/j.ymgme.2007.12.006
15. Giacconi R, Kanoni S, Mecocci P, Malavolta M, Richter D, Pierpaoli S, Costarelli L, Cipriano C, Muti E, Mangialasche F, Piacenza F, Tesei S, Galeazzi R, Theodoraki EV, Lattanzio F, Dedoussis G, Mocchegiani E (2010) Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort. J Nutr Biochem 21:1008–1014. doi:10.1016/j.jnutbio.2009.08.008
16. Giacconi R, Malavolta M, Costarelli L, Busco F, Galeazzi R, Bernardini G, Gasparini N, Mocchegiani E (2012) Comparison of intracellular zinc signals in non adherent lymphocytes from young–adult and elderly donors: role of zinc transporters (Zip family) and proinflammatory cytokines. J Nutr Biochem 23:1256–1263. doi:10.1016/j.jnutbio.2011.07.005
17. Giacconi R, Costarelli L, Malavolta M, Piacenza F, Galeazzi R, Gasparini N, Basso A, Mariani E, Fulop T, Rink L, Dedoussis G, Kanoni S, Herbein G, Jajte J, Busco F, Mocchegiani E (2014) Association among 1267 A/G HSP70-2, -308 G/A TNF-alpha polymorphisms and pro-inflammatory plasma mediators in old ZincAge population. Biogerontology 15:65–79. doi:10.1007/s10522-013-9480-1
18. Jandeleit-Dahm K, Cooper ME (2008) The role of AGEs in cardiovascular disease. Curr Pharm Des 14:979–986
19. Jansen J, Rosenkranz E, Overbeck S, Warmuth S, Mocchegiani E, Giacconi R, Weiskirchen R, Karges W, Rink L (2012) Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc. J Nutr Biochem 23:1458–1466. doi:10.1016/j.jnutbio.2011.09.008
20. Kanoni S, Dedoussis GV, Herbein G, Fulop T, Varin A, Jajte J, Rink L, Monti D, Mariani E, Malavolta M, Giacconi R, Marcellini F, Mocchegiani E (2010) Assessment of gene–nutrient interactions on inflammatory status of the elderly with the use of a zinc diet score—ZINCAGE study. J Nutr Biochem 21:526–531. doi:10.1016/j.jnutbio.2009.02.011
21. Kilhovd BK, Juutilainen A, Lehto S, Ronnemaa T, Torjesen PA, Birkeland KI, Berg TJ, Hanssen KF, Laakso M (2005) High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study. Arterioscler Thromb Vasc Biol 25:815–820
22. Lim M, Park L, Shin G, Hong H, Kang I, Park Y (2008) Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus. Ann N Y Acad Sci 1150:311–315. doi:10.1196/annals.1447.011
23. Lin RY, Reis ED, Dore AT, Lu M, Ghodsi N, Fallon JT, Fisher EA, Vlassara H (2002) Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. Atherosclerosis 163:303–311
24. Malavolta M, Costarelli L, Giacconi R, Muti E, Bernardini G, Tesei S, Cipriano C, Mocchegiani E (2006) Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry A 69:1043–1053
25. Malavolta M, Giacconi R, Piacenza F, Santarelli L, Cipriano C, Costarelli L, Tesei S, Pierpaoli S, Basso A, Galeazzi R, Lattanzio F, Mocchegiani E (2010) Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population. Biogerontology 11:309–319. doi:10.1007/s10522-009-9251-1
26. Maret W (2011) Redox biochemistry of mammalian metallothioneins. J Biol Inorg Chem 16:1079–1086. doi:10.1007/s00775-011-0800-0
27. Maret W, Krezel A (2007) Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol Med 13:371–375
28. Mariani E, Cornacchiola V, Polidori MC, Mangialasche F, Malavolta M, Cecchetti R, Bastiani P, Baglioni M, Mocchegiani E, Mecocci P (2006) Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status: results from the Zincage Project. Biogerontology 7:391–398
29. Mariani E, Mangialasche F, Feliziani FT, Cecchetti R, Malavolta M, Bastiani P, Baglioni M, Dedoussis G, Fulop T, Herbein G, Jajte J, Monti D, Rink L, Mocchegiani E, Mecocci P (2008a) Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. Exp Gerontol 43:445–451
30. Mariani E, Neri S, Cattini L, Mocchegiani E, Malavolta M, Dedoussis GV, Kanoni S, Rink L, Jajte J, Facchini A (2008b) Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1A and -174 IL-6 polymorphic alleles. Exp Gerontol 43:462–471. doi:10.1016/j.exger.2007.12.003
31. Mazzatti DJ, Malavolta M, White AJ, Costarelli L, Giacconi R, Muti E, Cipriano C, Powell JR, Mocchegiani E (2008) Effects of interleukin-6 -174C/G and metallothionein 1A +647A/C single-nucleotide polymorphisms on zinc-regulated gene expression in ageing. Exp Gerontol 43:423–432. doi:10.1016/j.exger.2008.01.007
32. Meplan C, Crosley LK, Nicol F, Horgan GW, Mathers JC, Arthur JR, Hesketh JE (2008) Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. Am J Clin Nutr 87:1019–1027
33. Miao X, Sun W, Fu Y, Miao L, Cai L (2013) Zinc homeostasis in the metabolic syndrome and diabetes. Front Med 7:31–52. doi:10.1007/s11684-013-0251-9
34. Mocchegiani E, Giacconi R, Costarelli L, Muti E, Cipriano C, Tesei S, Pierpaoli S, Giuli C, Papa R, Marcellini F, Gasparini N, Pierandrei R, Piacenza F, Mariani E, Monti D, Dedoussis G, Kanoni S, Herbein G, Fulop T, Rink L, Jajte J, Malavolta M (2008a) Zinc deficiency and IL-6 -174G/C polymorphism in old people from different European countries: effect of zinc supplementation. ZINCAGE study. Exp Gerontol 43:433–444. doi:10.1016/j.exger.2008.01.001
35. Mocchegiani E, Giacconi R, Malavolta M (2008b) Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol Med 14:419–428. doi:10.1016/j.molmed.2008.08.002
36. Mocchegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M (2012) Micronutrient (Zn, Cu, Fe)-gene interactions in ageing and inflammatory age-related diseases: implications for treatments. Ageing Res Rev 11:297–319. doi:10.1016/j.arr.2012.01.004
37. Munoz A, Petering DH, Shaw CF III (2000) Structure–reactivity relationships among metallothionein three-metal domains: role of non-cysteine amino acid residues in lobster metallothionein and human metallothionein-3. Inorg Chem 39:6114–6123
38. Park KH, Jang W, Kim KY, Kim JR, Cho KH (2010) Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence. Biochem Biophys Res Commun 392:295–300. doi:10.1016/j.bbrc.2009.12.179
39. Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ (2007) Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85:837–844
40. Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5:725–738. doi:10.1038/nprot.2010.5
41. Seet RC, Lee CY, Lim EC, Quek AM, Huang H, Huang SH, Looi WF, Long LH, Halliwell B (2011) Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis 219:231–239. doi:10.1016/j.atherosclerosis.2011.07.097
42. Seneviratne C, Dombi GW, Liu W, Dain JA (2011) The in vitro glycation of human serum albumin in the presence of Zn(II). J Inorg Biochem 105:1548–1554. doi:10.1016/j.jinorgbio.2011.09.001
43. Simm A, Wagner J, Gursinsky T, Nass N, Friedrich I, Schinzel R, Czeslik E, Silber RE, Scheubel RJ (2007) Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery? Exp Gerontol 42:668–675
44. Sokalingam S, Raghunathan G, Soundrarajan N, Lee SG (2012) A study on the effect of surface lysine to arginine mutagenesis on protein stability and structure using green fluorescent protein. PLoS ONE 7:e40410. doi:10.1371/journal.pone.0040410
45. Tupe RS, Agte VV (2010) Role of zinc along with ascorbic acid and folic acid during long-term in vitro albumin glycation. Br J Nutr 103:370–377. doi:10.1017/S0007114509991929
46. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H (2005) Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann NY Acad Sci 1043:461–466
47. Wong CP, Magnusson KR, Ho E (2013) Increased inflammatory response in aged mice is associated with age-related zinc deficiency and zinc transporter dysregulation. J Nutr Biochem 24:353–359. doi:10.1016/j.jnutbio.2012.07.005
48. Yamagishi S, Adachi H, Takeuchi M, Enomoto M, Furuki K, Matsui T, Nakamura K, Imaizumi T (2007a) Serum level of advanced glycation end-products (AGEs) is an independent determinant of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic general population. Horm Metab Res 39:845–848
49. Yamagishi S, Ueda S, Okuda S (2007b) Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders. Curr Pharm Des 13:2832–2836
50. Yang L, Li H, Yu T, Zhao H, Cherian MG, Cai L, Liu Y (2008) Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am J Physiol Endocrinol Metab 294:E987–E992. doi:10.1152/ajpendo.90234.2008
51. Zhuang X, Pang X, Zhang W, Wu W, Zhao J, Yang H, Qu W (2012) Effects of zinc and manganese on advanced glycation end products (AGEs) formation and AGEs-mediated endothelial cell dysfunction. Life Sci 90:131–139. doi:10.1016/j.lfs.2011.10.025